Mark W Hahn - Net Worth and Insider Trading
Mark W Hahn Net Worth
The estimated net worth of Mark W Hahn is at least $240 Million dollars as of 2024-04-26. Mark W Hahn is the CFO of Verona Pharma PLC and owns about 15,521,248 shares of Verona Pharma PLC (VRNA) stock worth over $240 Million. Mark W Hahn is also the CFO of Dova Pharmaceuticals Inc and owns about 9,024 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $253,033. Details can be seen in Mark W Hahn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark W Hahn has not made any transactions after 2023-08-07 and currently still holds the listed stock(s).
Transaction Summary of Mark W Hahn
Mark W Hahn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark W Hahn owns 2 companies in total, including Verona Pharma PLC (VRNA) , and ALSP Orchid Acquisition Corp I (ALOR) .
Click here to see the complete history of Mark W Hahn’s form 4 insider trades.
Insider Ownership Summary of Mark W Hahn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRNA | Verona Pharma PLC | 2023-08-07 | Chief Financial Officer |
| ALOR | ALSP Orchid Acquisition Corp I | 2021-11-18 | director |
Mark W Hahn Latest Holdings Summary
Mark W Hahn currently owns a total of 2 stocks. Among these stocks, Mark W Hahn owns 15,521,248 shares of Verona Pharma PLC (VRNA) as of August 7, 2023, with a value of $240 Million and a weighting of 99.89%. Mark W Hahn also owns 9,024 shares of Dova Pharmaceuticals Inc (DOVA) as of September 30, 2019, with a value of $253,033 and a weighting of 0.11%.
Latest Holdings of Mark W Hahn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRNA | Verona Pharma PLC | 2023-08-07 | 15,521,248 | 15.47 | 240,113,707 |
| DOVA | Dova Pharmaceuticals Inc | 2019-09-30 | 9,024 | 28.04 | 253,033 |
Holding Weightings of Mark W Hahn
Mark W Hahn Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark W Hahn has made a total of 13 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Verona Pharma PLC is the sale of 275,888 shares on August 7, 2023, which brought Mark W Hahn around $695,238.
According to the SEC Form 4 filings, Mark W Hahn has made a total of 2 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Dova Pharmaceuticals Inc is the sale of 775 shares on September 30, 2019, which brought Mark W Hahn around $21,700.
Insider Trading History of Mark W Hahn
- 1
Mark W Hahn Trading Performance
GuruFocus tracks the stock performance after each of Mark W Hahn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark W Hahn is 52.55%. GuruFocus also compares Mark W Hahn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark W Hahn within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark W Hahn's insider trading performs compared to the benchmark.
Performance of Mark W Hahn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 35.58 | 52.55 | 47.28 | |||
| Relative Return to S&P 500(%) | 29.05 | 39.56 | 30.55 |
Mark W Hahn Ownership Network
Ownership Network List of Mark W Hahn
Ownership Network Relation of Mark W Hahn
Mark W Hahn Owned Company Details
What does Verona Pharma PLC do?
Who are the key executives at Verona Pharma PLC?
Mark W Hahn is the Chief Financial Officer of Verona Pharma PLC. Other key executives at Verona Pharma PLC include Chief Medical Officer Kathleen A. Rickard , director & President and CEO David Zaccardelli , and General Counsel Claire Poll .
Verona Pharma PLC (VRNA) Insider Trades Summary
Over the past 18 months, Mark W Hahn made 6 insider transaction in Verona Pharma PLC (VRNA) with a net sale of 1,937,392. Other recent insider transactions involving Verona Pharma PLC (VRNA) include a net sale of 462,248 shares made by Kathleen A. Rickard , a net sale of 1,976,904 shares made by David Zaccardelli , and a net sale of 552,400 shares made by Claire Poll .
In summary, during the past 3 months, insiders sold 36,248 shares of Verona Pharma PLC (VRNA) in total and bought 0 shares, with a net sale of 36,248 shares. During the past 18 months, 18,174,498 shares of Verona Pharma PLC (VRNA) were sold and 193,736 shares were bought by its insiders, resulting in a net sale of 17,980,762 shares.
Verona Pharma PLC (VRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verona Pharma PLC Insider Transactions
Mark W Hahn Mailing Address
Above is the net worth, insider trading, and ownership report for Mark W Hahn. You might contact Mark W Hahn via mailing address: 6340 Quadrangle Drive, Suite 100, Chapel Hill Nc 27517.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
